List of Novaliq patents

Patents where

Current Assignee

Name

‌

Novaliq

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes	Patent 12005033 was granted and assigned to Novaliq on June, 2024 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	12005033	June 11, 2024
‌ US Patent 11987623 Stabilized antibody compositions	Patent 11987623 was granted and assigned to Novaliq on May, 2024 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11987623	May 21, 2024
‌ US Patent 11684589 Pharmaceutical compositions for use in the therapy of blepharitis	Patent 11684589 was granted and assigned to Novaliq on June, 2023 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11684589	June 27, 2023
‌ US Patent 11576893 Pharmaceutical compositions comprising nebivolol	Patent 11576893 was granted and assigned to Novaliq on February, 2023 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11576893	February 14, 2023
‌ US Patent 10507132 Topical administration method	Patent 10507132 was granted and assigned to Novaliq on December, 2019 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	10507132	December 17, 2019
‌ US Patent 10045996 Pharmaceutical composition for treatment of increased intraocular pressure	Patent 10045996 was granted and assigned to Novaliq on August, 2018 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	10045996	August 14, 2018
‌ US Patent 9757459 Liquid pharmaceutical composition for the delivery of active ingredients	Patent 9757459 was granted and assigned to Novaliq on September, 2017 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	9757459	September 12, 2017
‌ US Patent 11160865 Liquid pharmaceutical composition for the delivery of active ingredients	Patent 11160865 was granted and assigned to Novaliq on November, 2021 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	11160865	November 2, 2021
‌ US Patent 9757460 Stabilised protein compositions based on semifluorinated alkanes	Patent 9757460 was granted and assigned to Novaliq on September, 2017 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	9757460	September 12, 2017
‌ US Patent 11583513 Semifluorinated alkane compositions	Patent 11583513 was granted and assigned to Novaliq on February, 2023 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11583513	February 21, 2023
‌ US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes	Patent 10130707 was granted and assigned to Novaliq on November, 2018 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	10130707	November 20, 2018
‌ US Patent 9968678 Liquid pharmaceutical composition for the delivery of active ingredients	Patent 9968678 was granted and assigned to Novaliq on May, 2018 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	9968678	May 15, 2018
‌ US Patent 10449164 Methods of treating ocular disorders using semifluorinated alkanes	Patent 10449164 was granted and assigned to Novaliq on October, 2019 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	10449164	October 22, 2019
‌ US Patent 11324757 Pharmaceutical composition for treatment of increased intraocular pressure	Patent 11324757 was granted and assigned to Novaliq on May, 2022 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11324757	May 10, 2022
‌ US Patent 10369117 Compositions comprising mixtures of semifluorinated alkanes	Patent 10369117 was granted and assigned to Novaliq on August, 2019 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	10369117	August 6, 2019
‌ US Patent 11273174 Iodine compositions	Patent 11273174 was granted and assigned to Novaliq on March, 2022 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11273174	March 15, 2022
‌ US Patent 11413323 Ophthalmic composition for treatment of dry eye disease	Patent 11413323 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11413323	August 16, 2022
‌ US Patent 9241900 Liquid pharmaceutical composition for the treatment of a posterior eye disease	Patent 9241900 was granted and assigned to Novaliq on January, 2016 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	9241900	January 26, 2016
‌ US Patent 11400132 Ophthalmic compositions comprising ciclosporin	Patent 11400132 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	11400132	August 2, 2022
‌ US Patent 9308262 Pharmaceutical composition for administration to nails	Patent 9308262 was granted and assigned to Novaliq on April, 2016 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	9308262	April 12, 2016
‌ US Patent 10064944 Liquid pharmaceutical composition for the treatment of a posterior eye disease	Patent 10064944 was granted and assigned to Novaliq on September, 2018 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	10064944	September 4, 2018
‌ US Patent 10058615 Semifluorinated alkane compositions	Patent 10058615 was granted and assigned to Novaliq on August, 2018 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	10058615	August 28, 2018
‌ US Patent 10525062 Pharmaceutical composition for treatment of increased intraocular pressure	Patent 10525062 was granted and assigned to Novaliq on January, 2020 by the United States Patent and Trademark Office.		‌ Novaliq	United States Patent and Trademark Office	10525062	January 7, 2020
‌ US Patent 10273298 Stabilized antibody compositions	Patent 10273298 was granted and assigned to Novaliq on April, 2019 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	10273298	April 30, 2019
‌ US Patent 9770508 Semifluorinated alkane compositions	Patent 9770508 was granted and assigned to Novaliq on September, 2017 by the United States Patent and Trademark Office.	‌ Novaliq	‌ Novaliq	United States Patent and Trademark Office	9770508	September 26, 2017

Results per page:

41 results

0 selected

41 results

0 selected